Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

Aug 21, 2020, 20:30 ET Endo International plc Announces The Expiration And Final Tender Results Of Its Previously Announced Tender Offer

Endo International plc (the "Company") (NASDAQ: ENDP) announced today the expiration and final tender results of the previously announced cash tender ...


Aug 21, 2020, 18:00 ET Evofem Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Evofem Biosciences, Inc. (NASDAQ: EVFM), a commercial-stage biopharmaceutical company, today announced that on August 18, the Compensation Committee...


Aug 21, 2020, 16:56 ET Immunization Providers Need to Work Together to Increase Access to Lifesaving Childhood Vaccines

The leaders of 12 US pharmacy organizations today issued the following statement celebrating the U.S. Department of Human Services order this week...


Aug 21, 2020, 16:30 ET PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on August 18, 2020 it approved non-statutory stock options to purchase an aggregate of...


Aug 21, 2020, 12:48 ET Chesapeake Urology Named First Axonics® Center of Excellence in the U.S.

Three Chesapeake Urology physicians and their teams have been designated as Axonics Centers of Excellence by Axonics Modulation Technologies, Inc....


Aug 21, 2020, 10:31 ET JanOne to Host Telebriefing to Discuss Drug Candidate JAN101 for Treatment of Peripheral Artery Disease (PAD) and Potential Applications for COVID-19 Vascular Complications

JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive,...


Aug 21, 2020, 10:00 ET New Mucinex® GeoVitalPredictor (GVP) Puts Americans One Step Ahead of Cold and Flu Outbreaks

Knowing where sick will happen is more than half the battle. Mucinex®, a leading cold and flu brand with a fighting spirit, is joining forces with...


Aug 21, 2020, 09:28 ET Harbour BioMed Presented Its Newly Discovered BCMA x CD3 Bispecific Antibody at Cell Engager Summit 2020

Harbour BioMed (HBM), a global, clinical-stage, innovative biopharmaceutical company, presented its newly discovered Bispecific Antibody - BCMA x CD3 ...


Aug 21, 2020, 08:15 ET Kintara Therapeutics Announces Additional $2.4 Million Private Placement Priced At-The-Market

Kintara Therapeutics, Inc. (formerly DelMar Pharmaceuticals, Inc.) ("Kintara" or the "Company") (Nasdaq: KTRA) announced today that it has entered...


Aug 21, 2020, 08:11 ET Therapix Biosciences Announces Replacement of its Board of Directors

Therapix Biosciences Ltd. (OTC Pink: TRPXY) (the "Company"), a specialty, clinical-stage pharmaceutical company focusing on the development of...


Aug 21, 2020, 08:00 ET Kintara Therapeutics (formerly DelMar Pharmaceuticals) Regains Compliance with NASDAQ Minimum Bid Price Requirement

Kintara Therapeutics, Inc. (formerly DelMar Pharmaceuticals, Inc.) ("Kintara" or the "Company") (Nasdaq: KTRA) announced today that it has regained...


Aug 21, 2020, 07:30 ET Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Rigel Pharmaceuticals (Nasdaq: RIGL) today announced that it has granted awards pursuant to the Rigel Pharmaceuticals, Inc. Inducement Plan, approved ...


Aug 21, 2020, 07:00 ET Virtual FDA Advisory Committee Meeting to Review New Drug Application for ALKS 3831 for Treatment of Schizophrenia and Bipolar I Disorder Tentatively Scheduled for Oct. 9, 2020

Alkermes plc (Nasdaq: ALKS) today announced that a joint meeting of the U.S. Food and Drug Administration's (FDA) Psychopharmacologic Drugs Advisory...


Aug 21, 2020, 06:00 ET Cipla and Stempeutics collaborate for launch of Stempeucel®, first 'Made in India' Cell Therapy to treat Critical Limb Ischemia (CLI)

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as "Cipla" today announced that its partner Stempeutics Research Pvt. Ltd has received...


Aug 21, 2020, 05:00 ET Cipla e Stempeutics trabalham em parceria para o lançamento do Stempeucel®, a primeira terapia celular 'feita na Índia' para o tratamento da isquemia crítica de membros (ICM)

A Cipla Limited (BSE: 500087) (NSE: CIPLA EQ), denominada "Cipla", anunciou hoje que sua parceira Stempeutics Research Pvt. Ltd obteve a aprovação...


Aug 21, 2020, 05:00 ET Cipla y Stempeutics colaboran para el lanzamiento de Stempeucel®, primera terapia celular "hecha en India" para el tratamiento de la isquemia crítica de las extremidades (ICE)

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ), conocida como "Cipla", anunció hoy que su socio Stempeutics Research Pvt. Ltd ha recibido la aprobación...


Aug 21, 2020, 00:00 ET Cipla und Stempeutics kooperieren bei der Markteinführung von Stempeucel®, der ersten 'Made in India'-Zelltherapie zur Behandlung der kritischen Extremitätenischämie (CLI)

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (nachstehend "Cipla") gab heute bekannt, dass sein Partner Stempeutics Research Pvt. Ltd. die behördliche ...


Aug 21, 2020, 00:00 ET Cipla y Stempeutics colaboran para lanzar la terapia celular Stempeucel®

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ), denominada "Cipla", ha anunciado hoy que su socio Stempeutics Research Pvt. Ltd ha recibido la...


Aug 21, 2020, 00:00 ET Cipla et Stempeutics collaborent en vue du lancement de Stempeucel®, première thérapie cellulaire « Made in India » visant à traiter l'ischémie critique chronique des membres (ICC)

Cipla Limited (BSE : 500087) (NSE : CIPLA EQ), désignée ici sous le nom de « Cipla », a annoncé aujourd'hui que son partenaire Stempeutics Research...


Aug 20, 2020, 20:03 ET Mind Medicine (MindMed) Inc. Announces Q2 2020 Financial Results

Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF), the leading psychedelic pharmaceutical company, has announced its second quarter financial...


Aug 20, 2020, 18:10 ET Medicure Announces Termination of ReDS™ Pro Marketing and Distribution Agreement

STRENGTHENS FOCUS ON MARKETING OF AGGRASTAT® AND ZYPITAMAGTM WINNIPEG, MB, Aug. 20, 2020 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company")...


Aug 20, 2020, 17:33 ET FDA Approves New KYPROLIS® (carfilzomib) Combination Regimen With DARZALEX® (daratumumab) And Dexamethasone In Both Once- And Twice-Weekly Dosing Regimens

Amgen (NASDAQ:AMGN) today announced the U.S. Food and Drug Administration (FDA) has approved the expansion of the KYPROLIS® (carfilzomib) U.S....


Aug 20, 2020, 16:05 ET Cytocom, Inc. Announces Agreement to Reacquire Rights to Lead Drug Candidate CYTO-201 and CYTO-401 in Emerging Markets

Cytocom, Inc. (Cytocom), a clinical-stage biopharmaceutical company developing novel immune modulating therapies based on proprietary platforms,...


Aug 20, 2020, 16:01 ET BiondVax Announces Second Quarter 2020 Financial Results

BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a clinical stage biopharmaceutical company focused on developing and commercializing M-001, a universal ...


Aug 20, 2020, 15:00 ET Movimento reúne instituições para requalificar conversa sobre a Depressão no Brasil

Dar o primeiro passo nunca é fácil para quem tem Depressão. Falta de conhecimento, negação dos sintomas, crença de que "pode dar uma animada por...